Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib

Brittany Craiglow,Yang Won Lee,Sergio Vañó-Galván,Alexander Egeberg,Yves Dutronc,Frederick Durand,Evangeline Pierce,Guanglei Yu,Yun-Fei Chen,Arash Mostaghimi
DOI: https://doi.org/10.1007/s13555-024-01208-x
2024-06-22
Dermatology and Therapy
Abstract:Alopecia areata (AA) is an autoimmune disease associated with high rates of emotional and psychosocial distress. The analysis reported here describes the evolution of measures assessing health-related quality of life (HRQoL) and symptoms of anxiety and depression up to week 104 in patients who achieved sustained scalp hair regrowth during treatment with baricitinib in the BRAVE-AA phase III trials.
dermatology
What problem does this paper attempt to address?